|
|
|
|
|
Cancer Newsletter
|
|
|
|
Research News
|
Drug Says "Nope" to Brain Cancer Metastasis. read more
Antibiotics May be Key to Boosting Pancreatic Cancer Treatment. read more
Pap Test and ctDNA Analysis Detects Early-Stage Gynecologic Cancers. read more
Telomerase Inhibitor Takes on Drug Resistant Melanoma. read more
Protein Profiling Identifies New Prostate Cancer Biomarkers. read more
|
|
|
|
|
Product Reviews
|
|
PE Anti-Human TCR Vd2 Antibody
|
|
This antibody has been used in a flow cytometry based study immunophenotyping PBMC populations obtained from cancer patients. The results have not yet been published. A multi-colour antibody panel was... read more
|
|
|
Lipofectamine RNAiMAX
|
|
The goal of the project was to determine if the transcription factor NFIA mediates the cytotoxicity of a novel anti-cancer therapeutic. This product was used to knockdown NFIA in human melanoma cells.read more
|
|
|
More Reviews »
|
|
|
|
|
|
|
|
|
|
|
Events
|
|
Adaptive Designs in Clinical Trials
|
|
Adaptive Designs in Clinical Trials 2018 will continue the discussion on recent developments and applications of state-of-the-art adaptive design techniques in clinical research. Experienced industry experts from across the globe will discuss recent real-life applications of group sequential and ... read more
|
|
|
BioTech Pharma Summit: Bioprocessing & Cell Culture 2018
|
|
On 21 & 22 May 2018, Hong Kong will host the BioTech Pharma Summit: Bioprocessing & Cell Culture 2018. This meeting explores today’s evolving strategies and technologies for improving mammalian cell cultivation, including omics technologies and synthetic biology. Industry experts offer insights into... read more
|
|
|
More Events »
|
|
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA
|
|
You received this email because you are subscribed
to our database. Need to change your settings?
Email Settings or Unsubscribe
|
|